New drug trial offers hope for stiff, painful back condition
NCT ID NCT05303285
Summary
This study is testing the safety and effectiveness of the drug secukinumab in 100 Chinese adults with active ankylosing spondylitis, a painful inflammatory spine disease. Participants have not gotten enough relief from standard anti-inflammatory drugs and have not tried advanced biologic medications before. The goal is to see if this treatment can better control the disease, reduce pain and stiffness, and improve daily function and quality of life over a year.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANKYLOSING SPONDYLITIS (AS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of RheumatologyTongji Hospital
RECRUITINGWuhan, Hubei, 430030, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Tongji Hospital
RECRUITINGWuhan, Hubei, 430030, China
-
Tongji Hospital
RECRUITINGWuhan, Hubei, 430030, China
Contact Phone: •••-•••-••••
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.